KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,900
0.00 (0.00%)
At close: Dec 5, 2025
-12.36%
Market Cap 151.60B
Revenue (ttm) 90.11B
Net Income (ttm) 174.16M
Shares Out 10.91M
EPS (ttm) 16.15
PE Ratio 870.51
Forward PE n/a
Dividend 50.00 (0.37%)
Ex-Dividend Date Dec 29, 2025
Volume 6,600
Average Volume 7,518
Open 14,000
Previous Close 13,900
Day's Range 13,700 - 14,000
52-Week Range 12,900 - 18,710
Beta 1.23
RSI 60.16
Earnings Date n/a

About KOREA PHARMA

KOREA PHARMA Co., Ltd. . produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1974
Employees 134
Stock Exchange KOSDAQ
Ticker Symbol 032300
Full Company Profile

Financial Performance

In 2024, KOREA PHARMA's revenue was 81.28 billion, a decrease of -2.36% compared to the previous year's 83.24 billion. Earnings were 3.79 billion, an increase of 4426.69%.

Financial Statements

News

There is no news available yet.